Gideon M Hirschfield1, Elizabeth J Heathcote. 1. Liver Centre, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, Canada. gideon.hirschfield@uhn.on.ca
Abstract
PURPOSE OF REVIEW: Cholestatic liver injury is encountered across a wide variety of clinical scenarios ranging from toxin-induced, genetic, to autoimmune in nature. This review summarizes recent findings from what is a burgeoning clinical field. RECENT FINDINGS: We highlight observations from cell biology (intracellular signaling molecules), genetics (biliary transporters) and clinical studies (predictors of outcomes) that provide new directions for laboratory and clinical research. SUMMARY: Treatments for cholestasis and cholestatic syndromes remain largely nonspecific and often ineffective. With the increased precision with which the cell biology of the cholangiocyte and the clinical description of associated diseases such as primary biliary cirrhosis and sclerosing cholangitis are understood, new approaches are likely to arise.
PURPOSE OF REVIEW: Cholestatic liver injury is encountered across a wide variety of clinical scenarios ranging from toxin-induced, genetic, to autoimmune in nature. This review summarizes recent findings from what is a burgeoning clinical field. RECENT FINDINGS: We highlight observations from cell biology (intracellular signaling molecules), genetics (biliary transporters) and clinical studies (predictors of outcomes) that provide new directions for laboratory and clinical research. SUMMARY: Treatments for cholestasis and cholestatic syndromes remain largely nonspecific and often ineffective. With the increased precision with which the cell biology of the cholangiocyte and the clinical description of associated diseases such as primary biliary cirrhosis and sclerosing cholangitis are understood, new approaches are likely to arise.
Authors: Connor E Bodeman; Anika L Dzierlenga; Catherine M Tally; Ryan M Mulligan; April D Lake; Nathan J Cherrington; Susan C McKarns Journal: J Pharmacol Exp Ther Date: 2013-08-08 Impact factor: 4.030
Authors: Melitta Penz-Österreicher; Christoph H Österreicher; Michael Trauner Journal: Best Pract Res Clin Gastroenterol Date: 2011-04 Impact factor: 3.043
Authors: Lisa Reinhard; Christian Rupp; Hans-Dieter Riedel; Thomas Ruppert; Thomas Giese; Christa Flechtenmacher; Karl Heinz Weiss; Petra Kloeters-Plachky; Wolfgang Stremmel; Peter Schirmacher; Peter Sauer; Daniel Nils Gotthardt Journal: PLoS One Date: 2012-01-11 Impact factor: 3.240